EUVIMEDEUVIMED entdecken
Crossref

Patient Selection for Efficacious Mandibular Advancement Device Therapy in Obstructive Sleep Apnea: An Institutional Outcomes Analysis

Nainika Nanda iD, Aaron Robertson iD, David C Upton iD

Annals of Otology, Rhinology & Laryngology · 2025-08 · 134 (8) · 575-582

DOI: 10.1177/00034894251334725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Otology, Rhinology & Laryngology, online erschienen am 26.04.2025. Verfasst von Nainika Nanda und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Wisconsin-Madison, Madison, WI, USA. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Mandibular Advancement, Patient Selection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mandibular advancement devices (MADs) are a treatment option for obstructive sleep apnea/hypopnea syndrome (OSAHS); however, the ideal patient selection criteria continue to be refined.

Objectives

To determine the overall efficacy of a custom titratable MAD in treating a subset of OSAHS patients. A secondary objective was to determine predictive factors affecting treatment outcome for MAD therapy.

Methods

Retrospective analysis of a single otolaryngologist’s (DCU) experience in 86 patients with Friedman Stages 2 to 4 treated with a MAD (Thornton Adjustable Positioner) at an academic medical center.

Results

Therapeutic success as measured by type 3 home apnea test (HSAT) before and after proper MAD titration was defined as a 50% reduction in initial AHI or reduction of AHI to a mild severity below 15 events/hour. The 50% AHI reduction rate after MAD titration was 64% and the overall success rate inclusive of patients with reduction below 15 events/hour was 72.1%. MAD therapy significantly reduced the mean AHI (−10.4 ± 12.6), P < .001) and improved the minimum oxygen saturation (1.88 ± 5.79, P = .003). Significant reduction of OSAHS severity was seen across all treatment groups regardless of initial OSAHS severity: mild (55.9%), moderate (85%), severe (75%; P < .001 for all 3 groups). High BMI, advanced age, concentric velopharyngeal collapse pattern, prior pharyngeal surgery, and male sex were not statistically significant predictors of ineffectiveness.

Conclusions

MAD therapy for OSAHS in patients with Friedman Stages 2 to 4 is an effective treatment in 72% of cases and should be considered as an initial treatment option within this subset of patients, inclusive of those with initially severe, moderate, and mild OSAHS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveMandibular AdvancementPatient SelectionHumansMaleFemaleRetrospective StudiesMiddle AgedTreatment OutcomeAdultPolysomnographyAgedSeverity of Illness Index

Stichwörter der Autor:innen

apnea hypopnea indexintraoral devicemandibular advancement deviceobstructive sleep apneaoral appliance

Autor:innen und Institutionen

  • Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of California Los Angeles, CA, USA.

ORCID-Profile: Nainika Nanda, Aaron Robertson, David C Upton

Zitieren

APA

Nanda, N., Robertson, A., & Upton, D. C. (2025). Patient Selection for Efficacious Mandibular Advancement Device Therapy in Obstructive Sleep Apnea: An Institutional Outcomes Analysis. Annals of Otology, Rhinology & Laryngology, 134(8), 575-582. https://doi.org/10.1177/00034894251334725

Vancouver

Nanda N, Robertson A, Upton DC. Patient Selection for Efficacious Mandibular Advancement Device Therapy in Obstructive Sleep Apnea: An Institutional Outcomes Analysis. Annals of Otology, Rhinology & Laryngology. 2025;134(8):575-582. doi:10.1177/00034894251334725

BibTeX
@article{Nanda2025,
  author = {Nanda, Nainika and Robertson, Aaron and Upton, David C},
  title = {Patient Selection for Efficacious Mandibular Advancement Device Therapy in Obstructive Sleep Apnea: An Institutional Outcomes Analysis},
  journal = {Annals of Otology, Rhinology & Laryngology},
  year = {2025},
  volume = {134},
  number = {8},
  pages = {575--582},
  doi = {10.1177/00034894251334725}
}
Kostenlos starten →